National Institute for Health Research (NIHR) Older People and Frailty Policy Research Unit, Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK
National Institute for Health Research (NIHR) Older People and Frailty Policy Research Unit, Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK.
BMJ Open. 2021 Mar 22;11(3):e047051. doi: 10.1136/bmjopen-2020-047051.
Frailty is typically assessed in older populations. Identifying frailty in adults aged under 60 years may also have value, if it supports the delivery of timely care. We sought to identify how frailty is measured in younger populations, including evidence of the impact on patient outcomes and care.
A rapid review of primary studies was conducted.
Four databases, three sources of grey literature and reference lists of systematic reviews were searched in March 2020.
Eligible studies measured frailty in populations aged under 60 years using experimental or observational designs, published after 2000 in English.
Records were screened against review criteria. Study data were extracted with 20% of records checked for accuracy by a second researcher. Data were synthesised using a narrative approach.
We identified 268 studies that measured frailty in samples that included people aged under 60 years. Of these, 85 studies reported evidence about measure validity. No measures were identified that were designed and validated to identify frailty in younger groups. However, in populations that included people aged over under 60 years, cumulative deficit frailty indices, phenotype measures, the FRAIL Scale, the Liver Frailty Index and the Short Physical Performance Battery all demonstrated predictive validity for mortality and/or hospital admission. Evidence of criterion validity was rare. The extent to which measures possess validity across the younger adult age (18-59 years) spectrum was unclear. There was no evidence about the impact of measuring frailty in younger populations on patient outcomes and care.
Limited evidence suggests that frailty measures have predictive validity in younger populations. Further research is needed to clarify the validity of measures across the adult age spectrum, and explore the utility of measuring frailty in younger groups.
衰弱通常在老年人中进行评估。如果能够及时提供护理,那么在年龄在 60 岁以下的成年人中识别衰弱也可能具有价值。我们试图确定在年轻人群中如何衡量衰弱,包括对患者结局和护理的影响的证据。
对原始研究进行了快速审查。
2020 年 3 月,在四个数据库、三个灰色文献来源和系统评价的参考文献中进行了搜索。
使用实验或观察性设计在 60 岁以下人群中测量衰弱的合格研究,且发表于 2000 年后,语言为英文。
根据审查标准筛选记录。对 20%的记录由第二位研究人员进行准确性检查,提取研究数据。使用叙述方法对数据进行综合。
我们确定了 268 项在包括年龄在 60 岁以下人群的样本中测量衰弱的研究。其中,85 项研究报告了有关测量有效性的证据。没有发现专门为识别年轻人群的衰弱而设计和验证的测量方法。然而,在包括年龄在 60 岁以上的人群中,累积缺陷衰弱指数、表型测量、FRAIL 量表、肝脏衰弱指数和简短身体表现电池都显示出对死亡率和/或住院的预测有效性。关于标准有效性的证据很少。这些测量方法在年轻成年人群(18-59 岁)范围内的有效性程度尚不清楚。没有证据表明在年轻人群中测量衰弱对患者结局和护理的影响。
有限的证据表明,衰弱测量在年轻人群中具有预测有效性。需要进一步研究以明确整个成年年龄段的测量方法的有效性,并探讨在年轻人群中测量衰弱的效用。